Policy & Regulation
FDA Schedules July Review That Could Reshape the Research Peptide Landscape
A federal advisory review puts peptide compounding policy, research access, and regulatory oversight into sharper focus.
Read the report
Summer 2026 · Volume 1, Issue 1Explore the inaugural issue →
Editor’s selection
Essential reading
Perspectives
Influencers, Peptides, and Public Perception: Why the Conversation Is Growing
How social media, clinical language, and fast-moving wellness culture are shaping what the public thinks it knows about peptides.
Research & Reviews
Naturally Occurring Peptide Shows Promise in Melanoma Research
Researchers report early findings involving a naturally occurring peptide and a potential path for further melanoma research.
Industry
“Hot Peptide Summer?” Industry Watches Potential FDA Reclassification Discussions Closely
National coverage brings renewed attention to peptide policy as industry observers watch for possible regulatory movement.
Industry
How the Peptide Boom Is Going Global, and Where
The United States, Canada, Mexico, Japan, and Europe are responding to peptide interest through different scientific and regulatory systems.
Research & Reviews
The Delivery Problem: Why Peptides Are So Hard to Formulate
Oral absorption, enzymatic degradation, stability, and transport continue to make peptide delivery a demanding scientific problem.
The field in context
Research moves fast. Understanding needs room.
Research Pep News follows more than announcements. We track the scientific questions, regulatory decisions, market forces, and public narratives that determine what a peptide story actually means.
Explore the field
Browse all 34 launch stories →Departments
Research & Reviews
View department →Policy & Regulation
View department →Industry
View department →Perspectives
View department →Most read
Research & Reviews
The Delivery Problem: Why Peptides Are So Hard to Formulate
Research & Reviews